AMRN
Amarin Corporation plc
Company Overview
| Mkt Cap | $391.73M | Price | $16.29 |
| Volume | 99.92K | Change | -0.67% |
| P/E Ratio | -4.8 | Open | $16.35 |
| Revenue | $228.6M | Prev Close | $16.40 |
| Net Income | $-82.2M | 52W Range | $7.00 - $20.90 |
| Div Yield | N/A | Target | $10.67 |
| Overall | 48 | Value | 60 |
| Quality | 34 | Technical | 50 |
No chart data available
Stock Overview
Updated DailyAmarin Corporation plc (AMRN) is a leading Healthcare company in the Biotechnology industry, currently trading at $16.29 with a market capitalization of $391.73 million. The stock is positioned in the upper portion of its trading range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 34.
Today's trading session shows AMRN with a volume of 100K shares. The stock opened down 0.30% from yesterday's close of $16.40. Current analyst estimates project earnings of $0.04 per share for this year, with next year targeting $-0.1.
AMRN demonstrates neutral technical outlook based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including ABBV, TEVA, ALKS, GSK, AZN.
Key investment considerations for AMRN include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest limited upside of -34.5%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 07:17 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AMRN | $16.29 | -0.7% | 99.92K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |